BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.
The World Health Organisation (WHO) say that the XE COVID variant (a mixture of two strains of Omicron) could be 10% more transmissible than Omicron itself.
Understanding the infection strategy of mosquito-borne viruses known as flaviviruses is key in the future development of treatments and possible vaccines
Researchers find the best protection against COVID-19 is vaccinations rather than natural immunity, when analysing how infection with SARS-CoV-2 affects the immune system.
Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.
Separate to WHO efforts to conduct a technology transfer, Moderna signed a Memorandum of Understanding with Kenya to build the first mRNA factory in Africa.
